講演・口頭発表等 - 大川　龍之介

分割表示  294 件中 61 - 80 件目  ／  全件表示 >>

  1. Morita M., Ohkawa R., Satou M., Yoshimoto A., Yano K., Kasama T., Tozuka M. Modification of apolipoprotein A-I in high-density lipoprotein by myeloperoxidase and chymase. The 32nd World Congress of Biomedical Laboratory Science. 2016.09.02 Hyogo

  2. Ohkawa R., Tozuka M.. “What is” and “How to make” Leader of Biomedical Laboratory Scientist?. The 32nd World Congress of Biomedical Laboratory Science. 2016.09.02 Hyogo

  3. Kobayashi T., Kurano M., Nojiri T., Ohkawa R., Tozuka M., Okubo S., Yatomi Y. Oxidation and glycation modulate HDL capacity to carry Sphingosine 1-phosphate, an Anti-atherosclerotic Bioactive Lipid. The 32nd World Congress of Biomedical Laboratory Science. 2016.09.02 Hyogo

  4. Sato M., Ohkawa R., Yoshimoto A., Yano K., Okubo S., Yatomi Y., Tozuka M.. Effect of SAA on the antioxidant ability of HDL. American Association for Clinical Chemistry (AACC) 2016 Annual Meeting and Clinical Lab Expo 2016.07.31 Philadelphia

  5. Yano K., Ohkawa R., Sato M., Yoshimoto A., Kubota T., Tozuka M.. Effect of differentiation and foam cell formation on cholesterol efflux capacity of apolipoprotein A-I.. American Association for Clinical Chemistry (AACC) 2016 Annual Meeting and Clinical Lab Expo 2016.07.31 Philadelphia

  6. Yoshimoto A., Sato M., Yano K., Usami Y., Miyazaki A., Sugano M., Ohkawa R., Tozuka M. Paraoxonase1 participates in antioxidant ability of HDL as a constituent protein but not its enzymatic activity. the 21st IFCC-EFLM (European Congress of Clinical Chemistry and Laboratory Medicine) 2015.06.22 Paris

  7. Ohkawa R. IFCC TF-YS open meeting, Workforce preparation the invitation to contribution. the 21st IFCC-EFLM (European Congress of Clinical Chemistry and Laboratory Medicine) 2015.06.22 Paris

  8. Mamiya S., Yoshimoto A., Sato M., Ohkawa R., Tozuka M. Lipid hydroperoxides in apolipoprotein E-containing high-density lipoprotein. American Association for Clinical Chemistry (AACC) 2014 Annual Meeting and Clinical Lab Expo 2014.07.27 Chicago

  9. Kameda T., Usami Y., Sagae N., Ohkawa R., Tozuka M. Effects of myeloperoxidase-modified HDL on reverse cholesterol transport and monocytic migration. American Association for Clinical Chemistry (AACC) 2014 Annual Meeting and Clinical Lab Expo 2014.07.27 Chicago

  10. Sato M., Ohkawa R., Kameda T., Yoshimoto A., Okubo S., Yatomi Y., Tozuka M.. Effect of SAA on the structure and measurement method of HDL. American Association for Clinical Chemistry (AACC) 2014 Annual Meeting and Clinical Lab Expo 2014.07.27 Chicago

  11. Ohkawa R., Kishimoto T., Kurano M., Dohi T., Miyauchi K., Daida H., Nagasaki M., Uno K., Hayashi N., Sakai N., Matsuyama N., Nojiri T., Nakamura K., Okubo S., Yokota H., Ikeda H., Yatomi Y. Possible Usefulness of the Assay of Choline and Choline-containing Phospholipids in Clinical Laboratory Medicine in the Fields of Dyslipidemia and Atherosclerosis. Scientific Session of the American Heart Association 2013.11.03 Los Angeles

  12. Sugiura T., Dohi Y., Yamashita S., Ohte N., Ito S., Sanagawa A., Iwaki S. Ohkawa R., Mishima Y., Yatomi Y., Kimura G., Fujii S.. Circulating MicroRNA-126 as a Potential Biomarker for Recovery from Smoking-Related Endothelial Damage. Scientific Session of the American Heart Association 2013.11.03 Los Angeles

  13. Kurano M., Tsukamoto K., Ohkawa R., Hara M., Iino J., Ikeda H., Yatomi Y.. Hepatic Apolipoprotein M Overexpression Increased Total Sphingosine 1-phosphate Mass and Ameliorate Insulin Resistance in Diet Induced Obesity Mice. Scientific Session of the American Heart Association 2013.11.03 Los Angeles

  14. Fujii S., Iwaki S., Ito S., Nagasaki A., Ohkawa R., Yatomi Y., Furumoto T.. Increased Plasma Sphingosine-1-Phosphate (S1P) and Its Capacity to Increase Expression of Plasminogen Activator Inhibitor-1 In Adipocytes and Obese Subjects. Scientific Session of the American Heart Association 2013.11.03 Los Angeles

  15. Sawada T., Nakamura K., Ohkawa R., Shoji A., Tahara K., Hayashi H., Kimura E., Igarashi K., Aoki J. and Yatomi Y.. Serum Phosphatidylserine-Specific Phospholipase A1 (PS-PLA1) Identified As a Novel Biomarker for Systemic Lupus Erythematosus (SLE). ACR/ARHP Annual Meeting 2012.11.09

  16. 大川 龍之介. 臨床検査技師養成校における研究と外部資金獲得．. 第19回日本臨床検査学教育学会学術大会．教育シンポジウム１ 2025.08.21 岡山

  17. 五十嵐 菜緒，吉本 明，秋山 葉菜恵，染谷 優和，橋本 大知，孫 成満，宮腰 恒広，川口 莉奈，渡部 芽以，亀田 貴寛，高田 亮平，宮武 和正，鈴木 喜晴，大川 龍之介. 急性炎症に伴う血清アミロイドAの増加による高比重リポタンパクの抗酸化能の変化について．. 第19回日本臨床検査学教育学会学術大会 2025.08.21 岡山

  18. 長濱 悠真，飯沼 和奏，椛嶋 航也，吉本 明，大川 龍之介，亀田 貴寛. Myeloperoxidaseおよびchymaseによる高比重リポタンパク中Apolipoprotein Eの修飾と断片化. 第19回日本臨床検査学教育学会学術大会 2025.08.21 岡山

  19. 中谷 文香，宮腰 恒広，小山 祥美，吉本 明，大川 龍之介. 髄液コレステロール濃度測定を目指した蛍光物質を用いる高感度コレステロール濃度測定法の検討. 第19回日本臨床検査学教育学会学術大会 2025.08.21 岡山

  20. 山崎 あずさ，波木井 優奈，吉本 明，市村 直也，東田 修二，大川 龍之介. 赤血球コレステロール含有量と赤血球代謝の関連. 第57回日本動脈硬化学会総会・学術集会 2025.07.06

< 前のページ - 次のページ >

このページの先頭へ▲